Background. The pathophysiologic mechanisms that determine the severity of Mediterranean spotted fever (MSF) and the host-related and microbe-related risk factors for a fatal outcome are incompletely understood.
Mediterranean spotted fever (MSF), Israeli spotted fever (ISF), Indian tick typhus, and Astrakhan spotted fever are caused by distinct strains of Rickettsia conorii. These strains exhibit minor antigenic and genotypic differences and have been hypothesized to cause distinctive clinical signs, as well as disease of differing severity [1, 2] .
In Portugal, MSF is caused by R. conorii Malish and ISF strains [3] . The incidence of MSF was 8.4 infections per 10,000 inhabitants during 1989 -2005, a high rate compared with other countries in the Mediterranean basin in which MSF is endemic. In the past decade, an increasing number of cases of the malignant form of MSF have been described in Portuguese patients [4, 5] . Moreover, based on confirmed diagnoses in the Portuguese hospital database (Administração Central do Sistema de Saúde, Portuguese Ministry of Health), the number of admissions for MSF increased from 176 patients in 1994 to 446 patients in 2004 [6] . The case fatality rate during the same period was 3%-7% among hospitalized patients. In 1997, the case fatality rate was very high in 2 Portuguese hospitals, and in the Beja district, the rate reached 32% [4] .
A study conducted in Beja Hospital by Sousa et al. [4] from 1994 through 1998 to identify the risk factors associated with a fatal outcome indicated that delay in antibiotic treatment of rickettsial infection was not the ex-planation; instead, the risk of death was related to comorbidities such as diabetes mellitus. It was suspected that the fatal outcome might have been related to the ISF strain, which was isolated for the first time in Portugal in 1997 from patients with fatal infections [7] . The hypothesis was that the ISF strain might cause different clinical manifestations than those caused by the Malish strain, which could lead to a late clinical diagnosis and consequently, to a delay in treatment, thus resulting in a higher number of severe cases. In 2005, Sousa et al. evaluated the 3 main signs of infection-fever, rash, eschar-and severity of disease in patients infected with ISF and Malish strains [3] . They observed no statistically significant differences in the occurrence of signs, in particular, the presence or absence of an eschar, in 94 Portuguese patients infected with either the Malish or the ISF strains. In Israel, eschars caused by infection with the ISF strain have been described in only 4% of cases [8 -10] . Because our previous studies were not exhaustive, we conducted a larger study to determine the risk factors for death in Portuguese patients who had a diagnosis of MSF confirmed by identification of the strain causing the infection.
METHODS

Data Collection and Definitions
Patients were admitted to Portuguese hospitals with a clinical diagnosis of MSF confirmed by isolation of Rickettsia species from blood or detection of rickettsial DNA in skin biopsy sample by polymerase chain reaction (PCR) at the Portuguese National Institute of Health during 1994 -2006. Additionally, serum samples were tested for the presence of IgM and IgG antibodies against R. conorii. Epidemiological, clinical, and laboratory data were recorded at admission. The onset of symptoms was defined as the first day on which any of the following symptoms were observed: fever, chills, rash, headache, or gastrointestinal symptoms, such as nausea, vomiting, and/or diarrhea. Alcoholism was defined as ingestion of 120 g ethanol per day, as well as on the basis of reports from family members and/or a family physician about the patient's habits with respect to alcohol. Respiratory insufficiency was defined as failure of the exchange of oxygen and carbon dioxide, pO 2 Ͻ60 mm Hg or pCO 2 Ͼ55 mm Hg. Congestive heart failure was defined as class III or above on the New York Heart Association Functional Classification for Congestive Heart Failure. Appropriate antibiotic treatment was defined as therapy that included least 1 antibiotic to which R. conorii is susceptible. Severity of disease was scored on the basis of patient admission to the intensive care unit (ICU), Acute Physiology and Chronic Health Evaluation II score (data not shown), or death.
Laboratory Confirmation of MSF
Isolation of Rickettsia species from blood. A heparinized blood sample was collected from patients with a presumptive clinical diagnosis of MSF at hospital admission. Plasma was tested for rickettsial antibodies by immunofluorescence assay. Blood culture was performed to isolate Rickettsia, and the strain causing the infection was identified, as described elsewhere [11] .
DNA detection in skin biopsies. At admission, a punch biopsy was performed to obtain a 5-mm skin sample from the eschar, if present, or from a rash lesion. Informed consent was obtained from all subjects, and experiments were performed with approval of the ethical committees of the hospitals and the Portuguese National Institute of Health. DNA extraction, PCR, and strain characterization were performed, as described elsewhere [3] . Serologic analysis. The diagnosis of R. conorii infection was confirmed when serum samples obtained from patients with acute infection contained IgM antibodies at a titer of 32 and/or IgG titer of 128 or there was a 4-fold increase in titer between serum samples from patients with acute infection and samples from convalescent patients [12, 13] . The cutoff for a positive result for R. conorii infection was established by the Portguese National Institute of Health on the basis of previous studies in the Portuguese population and previous studies of Portugal as a country where MSF is endemic. Serum samples from convalescent patients were collected at least 15 days after samples obtained during acute infection.
Statistical analysis. Exploratory data analysis was performed by using tables of frequencies and central tendency and dispersion measures for continuous variables. Differences were evaluated by use of Fisher's exact test or Pearson's 2 test for categorical variables and by use of the Mann-Whitney test when continuous variables did not show a Gaussian distribution. Differences were considered to be significant at P р .05. The association between death and each factor was measured by an odds ratio (OR) obtained with univariate logistic regression models. The multiple logistic regression model was built by stepwise selection, using the criteria of P Ͻ .05 for selection variables and P Ͼ .10 for backward elimination. The goodness-of-fit of the final model was evaluated by means of Pearson's 2 test and the Hosmer-Lemeshow test. Data analysis was performed with Stata (version 9.0 software; Stata). MSF due to infection with the Malish or ISF strains of R. conorii was diagnosed in 65 males (46%) and 75 females (54%). The median age was 60.5 years. Six of the patients were not adults (i.e., Ͻ18 years old): 5 were Ͻ6 years old, and 1 was 12 years old. Forty patients (29%) were admitted to an ICU, 95 (67%) were admitted to a ward, and 5 (4%) were treated as outpatients. Death due to infection with Malish or ISF strains of R. conorii occurred in 29 adults (21%; 15 men and 14 women).
RESULTS
From
MSF was confirmed in 93 patients by isolation of Rickettsia species from blood and in 47 patients by detection of R. conorii DNA by PCR. Additionally, serologic analysis was performed on 138 serum samples obtained from patients with acute infection and 53 serum samples obtained from convalescent patients. Of the 138 serum samples from patients with acute infection, only 4 patients (3%) had a significant level of IgM and/or IgG antibodies against R. conorii (a titer of 32 and 128, respectively). In these 4 patients, the diagnoses were further confirmed by detection of rickettsial DNA in skin biopsy samples by PCR, while culture for Rickettsia was negative. Forty-six patients were diagnosed by seroconversion observed when serum samples obtained during acute infection were compared to those obtained during convalescence, which is considered as a strong evidence of recent infection. No significant level of IgM or IgG antibodies against R. conorii was detected in patients with fatal cases of MSF. The patient populations infected with R. conorii ISF or Malish strains, both those with fatal infections and those with nonfatal infections, were similar with respect to age, the period of time between the onset of symptoms and first visit to the physician, and length of hospitalization (table 1) . There was a delay of 1 day in receipt of treatment for patients with nonfatal Malish strain infection, compared with patients with nonfatal ISF strain infection (a median of 5 days vs. a median of 4 days). No significant difference in the incidence of underlying disease or history of animal contact was detected between patients infected with the ISF strain and patients infected with the Malish strain (table 2). Although there was no difference in the seasonal distribution of patients infected with either the ISF or Malish strain, a history of a recognized tick bite was more common in patients infected with the Malish strain than in those infected with the ISF strain (20 (table 2) , suggesting significant gastrointestinal involvement in patients with ISF strain infection. Third, compared with Malish strain-infected patients, a higher percentage of patients with ISF strain infection had significantly elevated serum levels of total bilirubin, ␥-glutamyl transferase, and alkaline phosphatase, among other altered parameters (table 2), suggesting greater hepatic involvement.
Of the 6 children infected with R. conorii, 4 were infected with the Malish strain and 2 with the ISF strain (table 3). The most severely ill child was a 12-year-old infected with Malish strain who did not receive treatment until the tenth day of illness. He developed encephalitis and thrombocytopenia and had markedly elevated serum levels of hepatic transaminases.
The most important observation in this study was a statistically significantly greater severity of disease in patients infected Analysis of the clinical and laboratory data for fatal and nonfatal infections provided a picture of the pathophysiology of severe MSF in a large series of patients who had been documented specifically to have been infected with R. conorii by isolation of Rickettsia species or by molecular diagnosis and genetic identification of the agent, rather than by a diagnosis based on clinical manifestations or serologic analysis that did not distinguish among various spotted fever-group rickettsioses. Patients with fatal cases of etiologically documented R. conorii infection were more likely to have severe involvement of multiple organ systems as indicated by significantly greater occurrence of petechial rash, nausea, vomiting, diarrhea, prostration, obtundation and/or confusion, dehydration, tachypnea, and hepatomegaly (table 4) Also, patients with fatal infection were more likely to have leukocytosis (Ͼ11,300 cells/L), prolonged partial thromboplastin time, and elevated serum concentrations of urea, creatinine, bilirubin, alanine transaminase, ␥-glutamyl transferase, alkaline phosphatase, and creatine kinase (table 4) Data on antimicrobial therapy were available for 129 adult patients (64 infected with the Malish strain and 65 infected with the ISF strain). Doxycycline was the drug most often used to treat patients with MSF; it was administered to 57 patients (89%) infected with the Malish strain and to 46 (71%) infected with the ISF strain. Doxycycline was used in combination with a fluoroquinolone for 2 patients (3%) infected with the Malish strain and for 7 patients (11%) infected with the ISF strain. Six patients (9%) infected with the ISF strain received therapy with a fluoroquinolone alone. Of 64 patients infected with the Malish strain, 2 (3%) received no treatment, 2 (3%) were treated with a ␤-lactam drug, and 1 (2%) was treated with rifampin. Of 65 patients infected with the ISF strain, 5 (8%) patients received no treatment and 1 (2%) was treated with a ␤-lactam drug. No statistically significant differences were found between the groups of patients with respect to therapeutic regimens (P ϭ .472). Among the 7 patients who did not receive treatment, 2 survived and 5 died.
Of the 6 child patients, 3 received treatment with a macrolide (azithromycin), 1 received chloramphenicol, and 1 received doxycycline. The 6-month-old child recovered without specific treatment. No fatal cases occurred in children (table 3) .
DISCUSSION
To our knowledge, this study represents the largest case series of patients with a confirmed diagnosis of MSF based on documentation of R. conorii infection and the largest series that includes identification of the strain, rather than only clinical diagnosis or non-species specific serologic diagnosis. Owing to the presence of shared protein and lipopolysaccharide antigens among spotted fever-group rickettsiae, it is extremely difficult to distinguish between infections due to closely related rickettsiae by serologic or immunohistochemical methods [14, 15] . In the Mediterranean basin, patients with similar clinical manifestations have been documented (by isolation of Rickettsia species) to be infected with R. sibirica mongolotimonae strain, R. akari, and R. massiliae, all of which would have produced antibodies that were cross-reactive with R. conorii [11, 16, 17] . Isolation and/or PCR detection followed by genetic characterization can determine the genotype of the organism to the level of genus, species, and strain. Previous studies by Sousa This is the first exhaustive study reporting the differences between patients infected with R. conorii Malish strain and patients infected with the ISF strain, as well as the microbe-related and host-related risk factors and the clinical manifestations associated with a fatal outcome. In general, patients infected with the ISF strain and patients infected with the Malish strain did not show many differences in epidemiological, clinical, or laboratory data. The most important findings documented here are that the ISF strain is more virulent than the Malish strain in the population investigated and alcoholism is a risk factor for fatal outcome in MSF. The microbial pathogenic mechanism by which the ISF strain causes more severe illness remains to be determined. With regard to host-related risk factors, previous studies have described alcoholic patients who developed severe MSF. However, the present study is the first statistical analysis involving a representative sample that documents alcoholism as a risk factor for severity of disease [19] . Our data suggest that gastrointestinal symptoms such as nausea, vomiting, and diarrhea (table 4) are prominent manifestations in patients with fatal MSF. However, these symptoms might have been related to central nervous system involvement if intracranial pressure was increased. (i.e., among the patients with fatal cases, there were many patients with obtundation and/or confusion [12 {67%} ]; rickettsial infection in severe or fatal cases may result in cerebral edema and increased intracranial pressure, which are features of rickettsial encephalitis, and nausea and vomiting could be gastrointestinal symptoms that reflect central nervous system involvement). Thus, the exact mechanism that accounts for the presence of marked gastrointestinal symptoms in patients with fatal cases is not yet clear. Furthermore, there were significantly greater gastrointestinal manifestations, such as nausea and vomiting, in patients with ISF strain infection. It is possible that infection with the virulent ISF strain causes inflammation of abdominal organs secondary to rickettsial growth in blood vessels in these tissues or systemic or local production of high levels of proinflammatory cytokines and chemokines. This conclusion is consistent with our previous study showing that patients with severe MSF had very high dermal levels of proinflammatory tumor necrosis factor-␣, enzymes that mediate intracellular bacterial elimination as well as tissue injury (i.e., inducible nitric oxide synthase and indoleamine dioxygenase), and RANTES, a chemokine that stimulates the migration and accumulation of T cells at the site of infection [20] .
Multiple logistic regression analysis revealed an independent significant association between the presence of hyperbilirubinemia and fatal outcome in a greater percentage of patients with ISF strain infection, compared to patients with Malish strain infection. Whether hyperbilirubinemia is related to cholestasis, hemolysis, or other mechanisms remains to be determined. Nevertheless, it is clearly evident that hepatic involvement marked by hepatomegaly and elevated serum levels of alanine transaminase, alkaline phosphatase, and ␥-glutamyl transferase is strongly associated with a fatal outcome. Histological studies have shown that the hepatic pathology in patients with MSF, namely focal necrosis and mononuclear lobular and portal triad inflammation, is not associated with fatal disease [21] . The lack of correlation between pathology and fatal disease in combination with the strong association between fatal disease and abnormal values for several laboratory markers of organ dysfunction confirm the clinical diagnosis of multiple organ system involvement as an important factor in fatal rickettsial diseases. Indeed, there was significant evidence of greater injury in numerous organ systems for patients with fatal cases, compared with those with nonfatal cases, including injury to vascular endothelium in the brain (obtundation and/or confusion), lungs (tachypnea), the coagulation system (prolonged partial thromboplastin time), and skin (petechial rash). Systemic hypotension with decreased renal perfusion and glomerular filtration rate are also most likely the pathophysiologic mechanism behind the greater incidence of acute renal failure in patients with fatal infections [22] . This study reveals a lower incidence of eschars in patients with MSF due to the ISF strain, compared with patients infected with the Malish strain. The significant difference in eschar formation between MSF due to the ISF strain and that due to the Malish strain was not detected in our previous study, which we attribute to the nonrepresentative number of patients involved in our previous analysis. Consistent with this conclusion is the finding that many patients infected with the Malish strain in this study also did not have an eschar, as described previously. Furthermore, the current study includes a larger number of patients with fatal infection who were infected with either the Malish or the ISF strain, and some of them did not have eschars. Similarly, the case fatality rate for ISF strain infection in this study was significantly greater than that for Malish strain infection (29% vs. 13%; P ϭ .02), and a greater percentage of ISF strain-infected patients required admission to the ICU, compared with Malish strain-infected patients (36% vs. 22%; P ϭ .061). It is not yet clear whether the lower incidence of eschar in patients with fatal ISF strain infection is a prognostic factor that indicates an ineffective or detrimental host immune response against Rickettsia or a confounding factor that causes delayed diagnosis of these patients and thus disease progression. We favor the first possibility because our data show that the ISF strain-infected patients received antirickettsial treatment earlier in the course of disease than the Malish strain-infected patients.
The substantial case fatality rate for MSF in Portugal differs remarkably from that reported in some other regions of the Mediterranean area, and there are notable differences between Portugal's rate and the rates of countries that are near Portugal, such as France and Spain. The possibility that some Rickettsia strains are more virulent than others is a reasonable hypothesis to examine in such areas. It is conceivable that another, less virulent human pathogen, such as R. massiliae or R. monacensis, might be the etiologic agent of spotted fever rickettsiosis in some geographic locations, such as in the northeast of Spain [23, 24] .
The reason for the more frequent occurrence of a history of tick bite in patients infected with the Malish strain is not evident. Although different vector species or tick stages could be hypothesized to have transmitted the infection without detection, most of the cases occurred in similar months for both strains, and Rhipicephalus sanguineus is the only recognized tick host of R. conorii in Portugal [25] .
The lower incidence of rash and eschar as well as Rickettsiaspecific IgM or IgG antibodies in patients with fatal cases emphasizes the need to consider the diagnosis of MSF for patients with unexplained febrile illness, even in the absence of these signs and serological markers, in regions where MSF is endemic. This study reveals that diagnosis by PCR amplification of rickettsial DNA from skin biopsy samples is a useful method for establishing the etiologic agent. PCR was the only method by which the diagnosis was established in 47 patients. Additionally, 8 patients were diagnosed by both PCR and blood culture. Of 109 skin biopsy samples examined by PCR in this study, 55 (50%) samples were positive and 54 (50%) were negative for rickettsial DNA. Among the patients with skin biopsy samples that were PCR-negative for rickettsial DNA, 22 patients had rickettsial infection confirmed by serologic analysis.
Further analysis of the genotype of the Rickettsia allows identification of the agent to the strain level with the potential for investigation of differences in specific hypothetical virulence factors including adhesins (outer membrane proteins A and B) [26 -28] , actin mobility (RickA) [29] , and membranolytic enzymes (phospholipase D and hemolysins A and C) [30 -32] . Advances in diagnosis and knowledge of the pathogenic mechanisms of rickettsioses require further attention.
